Efficacy of donepezil on secondary end points in a randomized, double-blind placebo-controlled study in severe Alzheimer's disease

被引：0
|
作者：
Eriksson, S
Winblad, B
Kilander, L
Batsman, S
Jansson-Blixt, C
Wetterholm, AL
Haglund, A
Minthon, L
机构：
[1] Umea Univ, Umea, Sweden
[2] Karolinska Inst, Stockholm, Sweden
[3] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden
[4] Kalix Vardcent, Dept Primary Care, Kalix, Sweden
[5] Pfizer Biostat, Taby, Sweden
[6] Pfizer Neurosci, Taby, Sweden
[7] Univ Hosp MAS, Neuropsychiat Clin, Malmo, Sweden
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2005年 / 17卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [31] Donepezil for cancer-related fatigue: A double-blind, randomized, placebo-controlled study
    Bruera, E.
    El Osta, B.
    Valero, V.
    Driver, L.
    Palmer, J.
    Pei, B.
    Shen, L.
    Poulter, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Pentoxifylline in severe sepsis: a double-blind, randomized placebo-controlled study
    KH Staubach
    J Schröder
    P Zabel
    F Stüber
    Critical Care, 2 (Suppl 1):
  • [33] A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease
    Sano, M.
    Bell, K. L.
    Galasko, D.
    Galvin, J. E.
    Thomas, R. G.
    van Dyck, C. H.
    Aisen, P. S.
    NEUROLOGY, 2011, 77 (06) : 556 - 563
  • [34] DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial - Reply
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Yaffe, K
    NEUROLOGY, 2004, 62 (06) : 1030 - 1030
  • [35] Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent
    M. Panisset
    S. Gauthier
    H. Moessler
    M. Windisch
    Journal of Neural Transmission, 2002, 109 : 1089 - 1104
  • [36] Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent
    Panisset, M
    Gauthier, S
    Moessler, H
    Windisch, M
    JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (7-8) : 1089 - 1104
  • [37] Cerebrolysin in Alzheimer's disease: A Randomized, Double-blind, Placebo-controlled Trial with a Neurotrophic Agent
    Ruther, E.
    Kasper, S.
    Moessler, H.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 57 - 58
  • [38] The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: A double-blind placebo-controlled study
    dos Santos Moraes, Walter Andre
    Poyares, Dalva Rollemberg
    Guilleminault, Christian
    Ramos, Luiz Roberto
    Ferreira Bertolucci, Paulo Henrique
    Tufik, Sergion
    SLEEP, 2006, 29 (02) : 199 - 205
  • [39] Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: Results from a 24-week, double-blind, placebo-controlled, Randomized trial
    Homma, Akira
    Imai, Yukimichi
    Tago, Hisao
    Asada, Takashi
    Shigeta, Masahiro
    Iwamoto, Toshihiko
    Takita, Masashi
    Arimoto, Itaru
    Koma, Hiroshi
    Ohbayashi, Toshio
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (05) : 399 - 407
  • [40] A double-blind, placebo-controlled study of tacrine in Chinese patients with Alzheimer's disease
    Wong, WJ
    Liu, HC
    Fuh, JL
    Wang, SJ
    Hsu, LC
    Wang, PN
    Sheng, WY
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (04) : 289 - 294
12345